News
04-20-2010, 10:22 PM
Bionovo, Inc. announced today that the US Patent and Trademark Office (USPTO) has issued a patent covering a method of using Bionovo's proprietary drug candidate Bezielle® (BZL101) for the treatment of metastatic breast cancer. The patent issued today is Bionovo's second issued patent, with over 70 other patent applications currently pending.
More... (http://www.news-medical.net/news/20100421/USPTO-issues-patent-covering-method-of-metastatic-breast-cancer-treatment-using-Bionovos-Bezielle.aspx)
More... (http://www.news-medical.net/news/20100421/USPTO-issues-patent-covering-method-of-metastatic-breast-cancer-treatment-using-Bionovos-Bezielle.aspx)